Acute effects of cannabis on core and co-occurring features associated with autism spectrum disorder in adults

Karhson et al. ·Scientific Reports Impact 4.4

Klarer Nutzen GRADE Moderat 0 Zitate

Stichproben = 111 Pat.

Dauerakute Effekte

EndpunktSymptomschwere-Rating

Verblindungn.a.

DesignBeobachtungsstudie (Real-World-Daten)

Kernaussage

Symptomschweregradswerte wurden um 73,09% von vor zu nach Cannabiskonsum reduziert.

Zusammenfassung

n=111 selbst-identifizierte autistische Erwachsene, Real-World-Tracking über Strainprint®-App; Symptom-Schwere-Reduktion um 73,09% von vor bis nach Cannabis-Konsum (Sensory Sensitivity, Repetitive Behaviors, Mental Control, Negative Affect). Höhere Dosis assoziiert mit stärkerer Reduktion repetitiver Verhaltensweisen, mentaler Kontrolle und negativem Affekt. Keine Kontrollgruppe; subjektive Selbsteinschätzung.

PopulationSelbstidentifizierte autistische Erwachsene, n=111

InterventionCannabis (verschiedene Sorten/Dosen, ad libitum, via Strainprint-App erfasst)

OutcomeSymptomschwere-Reduktion um 73,09% von vor zu nach der Cannabisanwendung; höhere Dosen prädizieren stärkere Reduktionen bei Repetitive Behaviors, Mental Control und Negative Affect

Vertrauen in die Evidenz

Moderat

Dritte von vier GRADE-Stufen, die Effektschätzung ist wahrscheinlich verlässlich.

Qualitätsprofil

Größe ★★★★★

Verblindung —

Effektstärke Klarer Nutzen

Zitate / Jahr ★★★★★

Autoren

Karhson DS, LaFrance EM, Cuttler C

DOI 10.1038/s41598-025-23472-3↗

Design: Beobachtungsstudie (Real-World-Daten)

Abstract

Pharmacological interventions that treat core and co-occurring features of autism spectrum disorder (ASD) are a persistent unmet need. As such, use of cannabis to manage ASD features is common in the autistic community. Yet, few studies have examined the acute effects of cannabis on symptoms associated with ASD. Therefore, we measured changes in symptom ratings from before to after cannabis use in a sample of 111 self-identified autistic adults. Anonymized archival data sourced from the Strainprint<sup>®</sup> app were analyzed. A subset of tracked information that reflected changes in core and co-occurring symptoms associated with ASD (i.e., Sensory Sensitivity, Repetitive Behaviors, Mental Control, and Negative Affect) were used to assess the impacts of cannabis on symptom severity. Overall, symptom severity ratings were reduced by 73.09% from before to after cannabis use. More severe symptoms were associated with greater reductions in severity ratings after use. Higher doses predicted greater reductions in severity of Repetitive Behaviors, Mental Control, and Negative Affect but dose of cannabis used to manage all symptoms remained static across time. Results from this first empirical examination of the perceived acute effects of cannabis in autistic adults suggest that cannabis provides temporary relief from symptoms associated with ASD.

„Was dem Handeln im Weg steht, wird zum Weg.“ — Marc Aurel